-
Product Insights
New![]()
Leo Solar Farm
Leo Solar Farm is a solar PV project located in Shizuoka, Japan. The project is owned and developed by Sermsang Power Corporation PLC. The project is currently partially active. Empower your strategies with our Leo Solar Farm report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business day of the purchase, excluding weekends and holidays. Certain sections of the report may...
-
Product Insights
New![]()
Leo Solar II PV Park
Leo Solar II PV Park is a solar PV project located in La Guajira, Colombia. The project is owned and being developed by Leo Solar SAS. Empower your strategies with our Leo Solar II PV Park report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business day of the purchase, excluding weekends and holidays. Certain sections of the report may be...
-
Product Insights
New![]()
Velto Leo Solar PV Park
Velto Leo Solar PV Park is a solar PV project located in Aragon, Spain. The project is owned by Caisse de depot et placement du Quebec. The project came online in 2008. Empower your strategies with our Velto Leo Solar PV Park report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business day of the purchase, excluding weekends and holidays. Certain...
-
Product Insights
New![]()
Leo Solar I PV Park
Leo Solar I PV Park is a solar PV project located in La Guajira, Colombia. The project is owned and being developed by Leo Solar SAS. Empower your strategies with our Leo Solar I PV Park report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business day of the purchase, excluding weekends and holidays. Certain sections of the report may be...
-
Company Insights
New![]()
Innovation and Patenting activity of LEO Group Co Ltd Q3 2023
GlobalData, the industry analysis specialist, has released its latest company patent databook "Innovation and Patenting activity of LEO Group Co Ltd Q3 2023". The databook highlights patenting activity of the company in terms of growth in filings and grants, regions protected, impact of various themes, sector applicability of technologies protected. It provides contextual analysis of technical peers, their strategy, dominance (Grant share) and their recent activities. This is an on-demand databook that will be delivered upon request. The report will...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – LEO-152020 in Chronic Urticaria Or Hives
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. LEO-152020 in Chronic Urticaria Or Hives Drug Details: LEO-152020 is under development for the treatment...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – LEO-152020 in Atopic Dermatitis (Atopic Eczema)
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. LEO-152020 in Atopic Dermatitis (Atopic Eczema) Drug Details: LEO-152020 is under development for the treatment...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – UNI-50002 in Atopic Dermatitis (Atopic Eczema)
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data.UNI-50002 in Atopic Dermatitis (Atopic Eczema)Drug Details:Orismilast (UNI-50002 and LEO 32731) is under development for the...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Olorinab in Abdominal Pain
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data.Olorinab in Abdominal PainDrug Details:Olorinab (APD-371) is under development for the treatment of visceral pain specifically...
-
Product Insights
New![]()
Rangapuram Mine
The Rangapuram Mine is a iron ore mine in India. It is currently in operation. Empower your strategies with our Rangapuram Mine report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Reasons to buy Gain vital...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Amyotrophic Lateral Sclerosis in Amyotrophic Lateral Sclerosis
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Amyotrophic Lateral Sclerosis in Amyotrophic Lateral Sclerosis Drug Details: Monoclonal antibody is under development...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – LP-0200 in Psoriasis
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalDatas proprietary machine learning algorithms developed using over 10 years of historical data.LP-0200 in Psoriasis Drug Details:LP-0200 is under development for the treatment of psoriasis. It acts by...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Izuforant in Atopic Dermatitis (Atopic Eczema)
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data.Izuforant in Atopic Dermatitis (Atopic Eczema)Drug Details:Izuforant is under development for the treatment of atopic dermatitis and...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Rheumatoid Arthritis in Rheumatoid Arthritis
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Rheumatoid Arthritis in Rheumatoid Arthritis Drug Details: The therapeutic candidate is under development for...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – JWP-1601 in Atopic Dermatitis (Atopic Eczema)
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. JWP-1601 in Atopic Dermatitis (Atopic Eczema) Drug Details: JWP-1601 is under development for...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – JNJ-74699157 in Non-Small Cell Lung Cancer
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalDatas proprietary machine learning algorithms developed using over 10 years of historical data.JNJ-74699157 in Non-Small Cell Lung Cancer Drug Details: JNJ-74699157 is under development for the treatment of...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – FOR-46 in Refractory Multiple Myeloma
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. FOR-46 in Refractory Multiple Myeloma Drug Details: FOR-46 is under development for the treatment...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – LP-0145 in Atopic Dermatitis (Atopic Eczema)
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalDatas proprietary machine learning algorithms developed using over 10 years of historical data.LP-0145 in Atopic Dermatitis (Atopic Eczema) Drug Details:LP-0145 (ARGX-112) is under development for the treatment of...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – (Polmacoxib + Tramadol) in Pain
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. (Polmacoxib + Tramadol) in Pain Drug Details: CG-650 is a fixed dose combination of polmacoxib...
-
Product Insights
New![]()
X-Linked Hypophosphatemic Rickets Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2023 Update
X-Linked Hypophosphatemic Rickets Clinical Trials Overview The X-Linked Hypophosphatemic Rickets clinical trial report consists of 55 trials. The report provides an overview of the X-Linked Hypophosphatemic Rickets clinical trial scenario. The report provides top-line data relating to the clinical trials on X-Linked Hypophosphatemic Rickets. It also includes an overview of trial numbers and their average enrolment in top countries conducted across the globe. Moreover, it offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status,...
Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.